Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since. 

Share:
More In Science
Good2Know: How Hotter Temperatures Are Impacting Sleep 
A new study shows that climate change is making it harder to fall asleep. The study, published in Cell Press over the weekend, shows that millions of people are already sleeping less because of higher overnight temperatures.
Load More